Polycystic Ovary Syndrome and Oocyte Developmental Competence
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Folliculogenesis is a complex process, in which multiple endocrine and intraovarian paracrine interactions create a changing intrafollicular microenvironment for appropriate oocyte development. Within this microenvironment, bidirectional cumulus cell-oocyte signaling governs the gradual acquisition of developmental competence by the oocyte, defined as the ability of the oocyte to complete meiosis and undergo fertilization, embryogenesis, and term development. These regulatory mechanisms of follicle growth, controlled in part by the oocyte itself, are susceptible to derangement in polycystic ovary syndrome (PCOS), a heterogeneous syndrome characterized by ovarian hyperandrogenism, insulin resistance, and paracrine dysregulation of follicle development. Consequently, only a subset of PCOS patients experience reduced pregnancy outcome after ovarian stimulation for in vitro fertilization. Recent data implicate functional associations between endocrine/paracrine abnormalities, metabolic dysfunction, and altered oocyte gene expression with impaired oocyte developmental competence in women with PCOS. Therefore, an understanding of how developmentally relevant endocrine/paracrine factors interact to promote optimal oocyte developmental is crucial to identify those PCOS patients who might benefit from long-term correction of follicle growth to improve fertility, optimize follicular responsiveness to gonadotropin therapy, and enhance pregnancy outcome by in vitro fertilization. Editor’s Note: Dr. Dumesic, the first author of the insightful and informative overview of the molecular and pathologic abnormalities underpinning the varying degrees of severity of polycystic ovary syndrome, presented a lecture on this topic at the annual meeting of the Endocrine Society in Toronto in June, 2007. I was so stimulated by his presentation that I asked him to write this review for the SURVEY. I hope that our readers find it as thoughtful and perceptive as I did—RBJ. (As a disclaimer: Dr. Dumesic was a postdoctoral reproductive endocrinology fellow in my laboratory from 1985 to 1987.) Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this article, the reader should be able to explain that oocyte developmental competence in patients with polycystic ovary syndrome (PCOS) is very complicated, with multiple interactions between endocrine, metabolic, and altered gene expression, and recall that it is related to a syndrome of ovarian hyperandrogenism, insulin resistance, and paracrine dysregulation of follicle development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 4×
“The National Institutes of Health-National Institute of Child Health and Human Development Conference of PCOS in 1990 recommended that the diagnostic criteria should be hyperandrogenism and/or hyperandrogenemia with oligoanovulation, excluding other endocrinopathies, including congenital adrenal hyperplasia, Cushing’s…”
BackgroundMethodInfluentialRegulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8088 · Cited by 405
Weil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359 · cited 1×
“Testosterone administration to adult female rhesus monkeys increases the number of primary, growing preantral and small antral follicles and the proliferation of granulosa cells within them (63,64).”
BackgroundVendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., & Bondy, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.353 · Cited by 324
Eldar-Geva, T., Spitz, I. M., Groome, N. P., Margalioth, E. J., & Homburg, R. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2552 · Cited by 94 · cited 1×
“Some PCOS patients also have low serum activin A levels with high serum concentrations of follistatin (a glycoprotein that binds to activin to inhibit its action (50,53,54), whereas others have an abnormal intrafollicular shift from an activin-dominant to an inhibindominant microenvironment during follicle growth (55–…”
Background
Cited by
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Self-citationPolycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“which suggests that genetic, environmental and hormonal interactions affect oocyte quality”
BackgroundSelf-citationOocyte environment: follicular fluid and cumulus cells are critical for oocyte health
Dumesic, D. A., Meldrum, D. R., Katz-Jaffe, M. G., Krisher, R. L., & Schoolcraft, W. B. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.11.015 · Cited by 640
Self-citationQiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis
Rittenberg, V., Seshadri, S., Sunkara, S. K., Sobaleva, S., Oteng-Ntim, E., & El-Toukhy, T. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.06.018 · Cited by 428
Metadata
- Authors
- Dumesic, D. A., Padmanabhan, V., & Abbott, D. H.
- Venue
- Obstetrical & Gynecological Survey
- Published
- 2008-01
- Volume
- 63
- Issue
- 1
- Pages
- 39-48
- ISSN
- 0029-7828 (ISSN-L)
- OpenAlex
- W1990637179
- Cited by
- 144
- References
- 9
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic Ovary Syndrome and Oocyte Developmental Competence. https://app.cochat.ai/papers/10.1097/ogx.0b013e31815e85fc
- The paper
- Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2008). Polycystic Ovary Syndrome and Oocyte Developmental Competence. Obstetrical & Gynecological Survey. https://doi.org/10.1097/ogx.0b013e31815e85fc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.